115 related articles for article (PubMed ID: 19628430)
21. Neuro-oncology: Bevacizumab prolongs progression-free survival but not overall survival in newly diagnosed glioblastoma.
Malkki H
Nat Rev Neurol; 2014 Apr; 10(4):179. PubMed ID: 24638136
[No Abstract] [Full Text] [Related]
22. End points for Phase II trials in recurrent glioblastoma: the cornerstone for a new era.
Franceschi E; Agati R; Brandes AA
Expert Rev Anticancer Ther; 2011 Nov; 11(11):1713-7. PubMed ID: 22050020
[TBL] [Abstract][Full Text] [Related]
23. Avastin's uncertain future in breast cancer treatment.
Twombly R
J Natl Cancer Inst; 2011 Mar; 103(6):458-60. PubMed ID: 21393607
[No Abstract] [Full Text] [Related]
24. Optic neuropathy in patients with glioblastoma receiving bevacizumab.
Sherman JH; Aregawi DG; Lai A; Fathallah-Shaykh HM; Bierman PJ; Linsky K; Larner JM; Newman SA; Schiff D
Neurology; 2009 Dec; 73(22):1924-6. PubMed ID: 19949039
[No Abstract] [Full Text] [Related]
25. The role of avastin in the management of recurrent glioblastoma.
Sweet JA; Feinberg ML; Sherman JH
Neurosurg Clin N Am; 2012 Apr; 23(2):331-41, x. PubMed ID: 22440876
[TBL] [Abstract][Full Text] [Related]
26. Thumbs up for Avastin.
Spalding BJ
Nat Biotechnol; 2008 Apr; 26(4):365. PubMed ID: 18392003
[No Abstract] [Full Text] [Related]
27. Case report of interstitial nephritis induced by bevacizumab therapy for glioblastoma multiforme.
Lomax AJ; Hill PA; Ashley DM
J Oncol Pharm Pract; 2013 Dec; 19(4):365-8. PubMed ID: 23235917
[TBL] [Abstract][Full Text] [Related]
28. Evolving strategies: future treatment of glioblastoma.
Chamberlain M
Expert Rev Neurother; 2011 Apr; 11(4):519-32. PubMed ID: 21469925
[TBL] [Abstract][Full Text] [Related]
29. FDA. Once on 'fast track,' avastin now derailed.
Couzin-Frankel J; Ogale Y
Science; 2011 Jul; 333(6039):143-4. PubMed ID: 21737712
[No Abstract] [Full Text] [Related]
30. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
Mrugala MM
Neurology; 2009 Feb; 72(8):773; author reply 773-4. PubMed ID: 19248218
[No Abstract] [Full Text] [Related]
31. Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?
Seystahl K; Weller M
Expert Opin Investig Drugs; 2012 May; 21(5):605-17. PubMed ID: 22413865
[TBL] [Abstract][Full Text] [Related]
32. Automatic multi-modal MR tissue classification for the assessment of response to bevacizumab in patients with glioblastoma.
Liberman G; Louzoun Y; Aizenstein O; Blumenthal DT; Bokstein F; Palmon M; Corn BW; Ben Bashat D
Eur J Radiol; 2013 Feb; 82(2):e87-94. PubMed ID: 23017192
[TBL] [Abstract][Full Text] [Related]
33. StatBite: Avastin Quarterly Sales, 2009-2011.
J Natl Cancer Inst; 2011 Aug; 103(15):1149. PubMed ID: 21768533
[No Abstract] [Full Text] [Related]
34. Recurrent glioblastoma: volumetric assessment and stratification of patient survival with early posttreatment magnetic resonance imaging in patients treated with bevacizumab.
Huang RY; Rahman R; Hamdan A; Kane C; Chen C; Norden AD; Reardon DA; Mukundun S; Wen PY
Cancer; 2013 Oct; 119(19):3479-88. PubMed ID: 23821555
[TBL] [Abstract][Full Text] [Related]
35. [Angiogenesis suppressing therapy applied to malignant glioma].
Takano S
Gan To Kagaku Ryoho; 2009 Jun; 36(6):941-7. PubMed ID: 19579331
[No Abstract] [Full Text] [Related]
36. Antiangiogenic therapy for patients with glioblastoma: current challenges in imaging and future directions.
Ahluwalia MS; Wen PY
Expert Rev Anticancer Ther; 2011 May; 11(5):653-6. PubMed ID: 21554035
[No Abstract] [Full Text] [Related]
37. Update on bevacizumab and other angiogenesis inhibitors for brain cancer.
Rinne ML; Lee EQ; Nayak L; Norden AD; Beroukhim R; Wen PY; Reardon DA
Expert Opin Emerg Drugs; 2013 Jun; 18(2):137-53. PubMed ID: 23668489
[TBL] [Abstract][Full Text] [Related]
38. [Anti-angiogenesis treatment for brain tumors: present and future].
Takano S; Matsumura A
No Shinkei Geka; 2006 Jul; 34(7):657-78. PubMed ID: 16841703
[No Abstract] [Full Text] [Related]
39. World's first delivery of intra-arterial bevacizumab directly into brain tumor of glioblastoma multiforme patients.
Expert Rev Anticancer Ther; 2010 Jan; 10(1):5. PubMed ID: 20014880
[No Abstract] [Full Text] [Related]
40. Avastin hearing leads to more uncertainty over drug's future.
Goozner M
J Natl Cancer Inst; 2011 Aug; 103(15):1148-50. PubMed ID: 21768534
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
